Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMANA INC Director's Dealing 2015

Feb 27, 2015

30145_dirs_2015-02-27_f57095bb-aaad-49bb-9c9f-d97083a5c161.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2015-02-25

Reporting Person: JONES DAVID A JR/KY (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-25 Humana Common G 6100 Disposed 133150 Direct
2015-02-25 Humana Common S 6100 $165.394 Disposed 127050 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Humana Common 1300 Indirect
Humana Common 1300 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Units $ Humana Common (5022) 5022 Direct
Restricted Stock Units $ Humana Common (95) 95 Direct

Footnotes

F1: Shares held by spouse as custodian for daughter.

F2: Shares held by spouse as custodian for son.

F3: Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F4: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F5: Includes 1,077 restricted stock units pursuant to the annual Director's Fee Program respresenting a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2015 if Reporting Person remains on the Board.

F6: Shares sold at prices ranging from $165.38 to $165.44